Laboratorios Farmaceuticos Rovi, S.A.
Laboratorios Farmaceuticos Rovi, S.A. LABFF Peers
See (LABFF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LABFF | $90.61 | N/A | 4.63B | 28.95 | $3.13 | +1.38% |
| NONOF | $67.50 | +2.27% | 299.64B | 19.18 | $3.52 | +2.46% |
| CSLLY | $78.33 | -0.18% | 151.71B | 28.80 | $2.72 | +1.69% |
| CMXHF | $150.96 | -7.39% | 73.10B | 27.70 | $5.45 | +1.83% |
| UCBJY | $90.81 | +0.65% | 34.52B | 29.68 | $3.06 | +0.60% |
| ARGNF | $562.00 | N/A | 34.32B | 34.25 | $16.41 | N/A |
| UCBJF | $175.75 | +4.21% | 33.40B | 28.72 | $6.12 | +0.74% |
| ODTC | $22,005.00 | +29.44% | 24.14B | -0.08 | -$268,995.00 | N/A |
| WXXWY | $6.14 | +0.82% | 12.47B | 27.91 | $0.22 | N/A |
| GNMSF | $199.35 | +5.59% | 12.25B | 11.69 | $17.05 | N/A |
Stock Comparison
LABFF vs NONOF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, NONOF has a market cap of 299.64B. Regarding current trading prices, LABFF is priced at $90.61, while NONOF trades at $67.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas NONOF's P/E ratio is 19.18. In terms of profitability, LABFF's ROE is +0.39%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, LABFF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs CSLLY Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, CSLLY has a market cap of 151.71B. Regarding current trading prices, LABFF is priced at $90.61, while CSLLY trades at $78.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas CSLLY's P/E ratio is 28.80. In terms of profitability, LABFF's ROE is +0.39%, compared to CSLLY's ROE of +0.15%. Regarding short-term risk, LABFF is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs CMXHF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, CMXHF has a market cap of 73.10B. Regarding current trading prices, LABFF is priced at $90.61, while CMXHF trades at $150.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas CMXHF's P/E ratio is 27.70. In terms of profitability, LABFF's ROE is +0.39%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, LABFF is less volatile compared to CMXHF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs UCBJY Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, UCBJY has a market cap of 34.52B. Regarding current trading prices, LABFF is priced at $90.61, while UCBJY trades at $90.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas UCBJY's P/E ratio is 29.68. In terms of profitability, LABFF's ROE is +0.39%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, LABFF is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs ARGNF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, ARGNF has a market cap of 34.32B. Regarding current trading prices, LABFF is priced at $90.61, while ARGNF trades at $562.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas ARGNF's P/E ratio is 34.25. In terms of profitability, LABFF's ROE is +0.39%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, LABFF and ARGNF have similar daily volatility (0.00).
LABFF vs UCBJF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, UCBJF has a market cap of 33.40B. Regarding current trading prices, LABFF is priced at $90.61, while UCBJF trades at $175.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas UCBJF's P/E ratio is 28.72. In terms of profitability, LABFF's ROE is +0.39%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, LABFF and UCBJF have similar daily volatility (0.00).
LABFF vs ODTC Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, ODTC has a market cap of 24.14B. Regarding current trading prices, LABFF is priced at $90.61, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas ODTC's P/E ratio is -0.08. In terms of profitability, LABFF's ROE is +0.39%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, LABFF and ODTC have similar daily volatility (0.00).
LABFF vs WXXWY Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, WXXWY has a market cap of 12.47B. Regarding current trading prices, LABFF is priced at $90.61, while WXXWY trades at $6.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas WXXWY's P/E ratio is 27.91. In terms of profitability, LABFF's ROE is +0.39%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, LABFF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs GNMSF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, GNMSF has a market cap of 12.25B. Regarding current trading prices, LABFF is priced at $90.61, while GNMSF trades at $199.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas GNMSF's P/E ratio is 11.69. In terms of profitability, LABFF's ROE is +0.39%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, LABFF is less volatile compared to GNMSF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs WXIBF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, WXIBF has a market cap of 12.19B. Regarding current trading prices, LABFF is priced at $90.61, while WXIBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas WXIBF's P/E ratio is 27.27. In terms of profitability, LABFF's ROE is +0.39%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, LABFF and WXIBF have similar daily volatility (0.00).
LABFF vs IVBXF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, IVBXF has a market cap of 11.67B. Regarding current trading prices, LABFF is priced at $90.61, while IVBXF trades at $7.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas IVBXF's P/E ratio is -707.54. In terms of profitability, LABFF's ROE is +0.39%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, LABFF is less volatile compared to IVBXF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs SBMFF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, SBMFF has a market cap of 8.86B. Regarding current trading prices, LABFF is priced at $90.61, while SBMFF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas SBMFF's P/E ratio is 49.50. In terms of profitability, LABFF's ROE is +0.39%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, LABFF is less volatile compared to SBMFF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs SBHMY Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, SBHMY has a market cap of 8.48B. Regarding current trading prices, LABFF is priced at $90.61, while SBHMY trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas SBHMY's P/E ratio is 32.69. In terms of profitability, LABFF's ROE is +0.39%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, LABFF is less volatile compared to SBHMY. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs TRSBF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, TRSBF has a market cap of 6.01B. Regarding current trading prices, LABFF is priced at $90.61, while TRSBF trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas TRSBF's P/E ratio is 28.33. In terms of profitability, LABFF's ROE is +0.39%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, LABFF is less volatile compared to TRSBF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs TLPPF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, TLPPF has a market cap of 5.67B. Regarding current trading prices, LABFF is priced at $90.61, while TLPPF trades at $16.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas TLPPF's P/E ratio is 186.43. In terms of profitability, LABFF's ROE is +0.39%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, LABFF is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs ABCZF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, ABCZF has a market cap of 5.12B. Regarding current trading prices, LABFF is priced at $90.61, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, LABFF's ROE is +0.39%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, LABFF and ABCZF have similar daily volatility (0.00).
LABFF vs INCPF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, INCPF has a market cap of 4.88B. Regarding current trading prices, LABFF is priced at $90.61, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas INCPF's P/E ratio is -108.67. In terms of profitability, LABFF's ROE is +0.39%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, LABFF and INCPF have similar daily volatility (0.00).
LABFF vs AKBLF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, AKBLF has a market cap of 4.75B. Regarding current trading prices, LABFF is priced at $90.61, while AKBLF trades at $21.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas AKBLF's P/E ratio is 33.89. In terms of profitability, LABFF's ROE is +0.39%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, LABFF is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs ZLDPF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, ZLDPF has a market cap of 4.48B. Regarding current trading prices, LABFF is priced at $90.61, while ZLDPF trades at $63.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas ZLDPF's P/E ratio is -24.49. In terms of profitability, LABFF's ROE is +0.39%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, LABFF is less volatile compared to ZLDPF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs SHJBF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, SHJBF has a market cap of 3.72B. Regarding current trading prices, LABFF is priced at $90.61, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas SHJBF's P/E ratio is -7.30. In terms of profitability, LABFF's ROE is +0.39%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, LABFF and SHJBF have similar daily volatility (0.00).
LABFF vs REGMF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, REGMF has a market cap of 3.37B. Regarding current trading prices, LABFF is priced at $90.61, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas REGMF's P/E ratio is -13.32. In terms of profitability, LABFF's ROE is +0.39%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, LABFF is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs CAMRF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, CAMRF has a market cap of 3.28B. Regarding current trading prices, LABFF is priced at $90.61, while CAMRF trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas CAMRF's P/E ratio is 59.57. In terms of profitability, LABFF's ROE is +0.39%, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, LABFF is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs GNNSF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, GNNSF has a market cap of 2.90B. Regarding current trading prices, LABFF is priced at $90.61, while GNNSF trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas GNNSF's P/E ratio is -16.94. In terms of profitability, LABFF's ROE is +0.39%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, LABFF is less volatile compared to GNNSF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs TKBIF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, TKBIF has a market cap of 2.79B. Regarding current trading prices, LABFF is priced at $90.61, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, LABFF's ROE is +0.39%, compared to TKBIF's ROE of N/A. Regarding short-term risk, LABFF and TKBIF have similar daily volatility (0.00).
LABFF vs MPSYF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, MPSYF has a market cap of 2.76B. Regarding current trading prices, LABFF is priced at $90.61, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, LABFF's ROE is +0.39%, compared to MPSYF's ROE of +7.43%. Regarding short-term risk, LABFF is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs ASPHF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, ASPHF has a market cap of 2.24B. Regarding current trading prices, LABFF is priced at $90.61, while ASPHF trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, LABFF's ROE is +0.39%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, LABFF and ASPHF have similar daily volatility (0.00).
LABFF vs BVNKF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, BVNKF has a market cap of 2.09B. Regarding current trading prices, LABFF is priced at $90.61, while BVNKF trades at $26.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas BVNKF's P/E ratio is 10.63. In terms of profitability, LABFF's ROE is +0.39%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, LABFF is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs BVNRY Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, BVNRY has a market cap of 2.00B. Regarding current trading prices, LABFF is priced at $90.61, while BVNRY trades at $8.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas BVNRY's P/E ratio is 10.22. In terms of profitability, LABFF's ROE is +0.39%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, LABFF is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs BTTAY Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, BTTAY has a market cap of 1.92B. Regarding current trading prices, LABFF is priced at $90.61, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas BTTAY's P/E ratio is -69.23. In terms of profitability, LABFF's ROE is +0.39%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, LABFF is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs MEOBF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, MEOBF has a market cap of 1.82B. Regarding current trading prices, LABFF is priced at $90.61, while MEOBF trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas MEOBF's P/E ratio is -15.89. In terms of profitability, LABFF's ROE is +0.39%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, LABFF is less volatile compared to MEOBF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs GLPGF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, GLPGF has a market cap of 1.81B. Regarding current trading prices, LABFF is priced at $90.61, while GLPGF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas GLPGF's P/E ratio is -9.02. In terms of profitability, LABFF's ROE is +0.39%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, LABFF is less volatile compared to GLPGF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs GENSF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, GENSF has a market cap of 1.78B. Regarding current trading prices, LABFF is priced at $90.61, while GENSF trades at $27.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas GENSF's P/E ratio is -338.75. In terms of profitability, LABFF's ROE is +0.39%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, LABFF is less volatile compared to GENSF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs PPTDF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, PPTDF has a market cap of 1.75B. Regarding current trading prices, LABFF is priced at $90.61, while PPTDF trades at $13.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas PPTDF's P/E ratio is 17.35. In terms of profitability, LABFF's ROE is +0.39%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, LABFF is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs BRCTF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, BRCTF has a market cap of 1.68B. Regarding current trading prices, LABFF is priced at $90.61, while BRCTF trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas BRCTF's P/E ratio is -90.40. In terms of profitability, LABFF's ROE is +0.39%, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, LABFF is less volatile compared to BRCTF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs BIESF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, BIESF has a market cap of 1.62B. Regarding current trading prices, LABFF is priced at $90.61, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas BIESF's P/E ratio is -45.71. In terms of profitability, LABFF's ROE is +0.39%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, LABFF and BIESF have similar daily volatility (0.00).
LABFF vs ONTTF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, ONTTF has a market cap of 1.58B. Regarding current trading prices, LABFF is priced at $90.61, while ONTTF trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas ONTTF's P/E ratio is -7.86. In terms of profitability, LABFF's ROE is +0.39%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, LABFF is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs PHMMF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, PHMMF has a market cap of 1.42B. Regarding current trading prices, LABFF is priced at $90.61, while PHMMF trades at $80.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas PHMMF's P/E ratio is 64.21. In terms of profitability, LABFF's ROE is +0.39%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, LABFF is less volatile compared to PHMMF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs CSBTF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, CSBTF has a market cap of 1.15B. Regarding current trading prices, LABFF is priced at $90.61, while CSBTF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas CSBTF's P/E ratio is -250.00. In terms of profitability, LABFF's ROE is +0.39%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, LABFF and CSBTF have similar daily volatility (0.00).
LABFF vs NURPF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, NURPF has a market cap of 1.02B. Regarding current trading prices, LABFF is priced at $90.61, while NURPF trades at $8.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas NURPF's P/E ratio is 11.63. In terms of profitability, LABFF's ROE is +0.39%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, LABFF is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs ASCLF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, ASCLF has a market cap of 821.88M. Regarding current trading prices, LABFF is priced at $90.61, while ASCLF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas ASCLF's P/E ratio is -21.19. In terms of profitability, LABFF's ROE is +0.39%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, LABFF is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs CSPHF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, CSPHF has a market cap of 702.96M. Regarding current trading prices, LABFF is priced at $90.61, while CSPHF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas CSPHF's P/E ratio is -51.80. In terms of profitability, LABFF's ROE is +0.39%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, LABFF is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs PHGUF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, PHGUF has a market cap of 680.31M. Regarding current trading prices, LABFF is priced at $90.61, while PHGUF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas PHGUF's P/E ratio is -50.00. In terms of profitability, LABFF's ROE is +0.39%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, LABFF and PHGUF have similar daily volatility (0.00).
LABFF vs BPMUF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, BPMUF has a market cap of 582.74M. Regarding current trading prices, LABFF is priced at $90.61, while BPMUF trades at $47.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas BPMUF's P/E ratio is 6.85. In terms of profitability, LABFF's ROE is +0.39%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, LABFF is less volatile compared to BPMUF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs INRLF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, INRLF has a market cap of 543.23M. Regarding current trading prices, LABFF is priced at $90.61, while INRLF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas INRLF's P/E ratio is -5.16. In terms of profitability, LABFF's ROE is +0.39%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, LABFF and INRLF have similar daily volatility (0.00).
LABFF vs SOLTF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, SOLTF has a market cap of 531.31M. Regarding current trading prices, LABFF is priced at $90.61, while SOLTF trades at $5.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas SOLTF's P/E ratio is -34.76. In terms of profitability, LABFF's ROE is +0.39%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, LABFF is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs IVEVF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, IVEVF has a market cap of 505.87M. Regarding current trading prices, LABFF is priced at $90.61, while IVEVF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas IVEVF's P/E ratio is -1.05. In terms of profitability, LABFF's ROE is +0.39%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, LABFF and IVEVF have similar daily volatility (0.00).
LABFF vs CLTEF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, CLTEF has a market cap of 504.72M. Regarding current trading prices, LABFF is priced at $90.61, while CLTEF trades at $7.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas CLTEF's P/E ratio is -7.06. In terms of profitability, LABFF's ROE is +0.39%, compared to CLTEF's ROE of -0.61%. Regarding short-term risk, LABFF and CLTEF have similar daily volatility (0.00).
LABFF vs CYDY Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, CYDY has a market cap of 480.65M. Regarding current trading prices, LABFF is priced at $90.61, while CYDY trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas CYDY's P/E ratio is -19.50. In terms of profitability, LABFF's ROE is +0.39%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, LABFF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs VBIZF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, VBIZF has a market cap of 472.97M. Regarding current trading prices, LABFF is priced at $90.61, while VBIZF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas VBIZF's P/E ratio is 22.70. In terms of profitability, LABFF's ROE is +0.39%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, LABFF and VBIZF have similar daily volatility (0.00).
LABFF vs SNBIF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, SNBIF has a market cap of 471.70M. Regarding current trading prices, LABFF is priced at $90.61, while SNBIF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas SNBIF's P/E ratio is -22.59. In terms of profitability, LABFF's ROE is +0.39%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, LABFF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs CKDXF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, CKDXF has a market cap of 470.61M. Regarding current trading prices, LABFF is priced at $90.61, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, LABFF's ROE is +0.39%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, LABFF is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs AAVXF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, AAVXF has a market cap of 457.38M. Regarding current trading prices, LABFF is priced at $90.61, while AAVXF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas AAVXF's P/E ratio is -2.30. In terms of profitability, LABFF's ROE is +0.39%, compared to AAVXF's ROE of -1.10%. Regarding short-term risk, LABFF and AAVXF have similar daily volatility (0.00).
LABFF vs BXPHF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, BXPHF has a market cap of 449.41M. Regarding current trading prices, LABFF is priced at $90.61, while BXPHF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas BXPHF's P/E ratio is -23.00. In terms of profitability, LABFF's ROE is +0.39%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, LABFF and BXPHF have similar daily volatility (0.00).
LABFF vs TBGNF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, TBGNF has a market cap of 433.72M. Regarding current trading prices, LABFF is priced at $90.61, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, LABFF's ROE is +0.39%, compared to TBGNF's ROE of N/A. Regarding short-term risk, LABFF and TBGNF have similar daily volatility (0.00).
LABFF vs NWBO Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, NWBO has a market cap of 416.93M. Regarding current trading prices, LABFF is priced at $90.61, while NWBO trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas NWBO's P/E ratio is -4.14. In terms of profitability, LABFF's ROE is +0.39%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, LABFF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs HBMHF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, HBMHF has a market cap of 407.69M. Regarding current trading prices, LABFF is priced at $90.61, while HBMHF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas HBMHF's P/E ratio is 16.07. In terms of profitability, LABFF's ROE is +0.39%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, LABFF and HBMHF have similar daily volatility (0.00).
LABFF vs PTCHF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, PTCHF has a market cap of 403.52M. Regarding current trading prices, LABFF is priced at $90.61, while PTCHF trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas PTCHF's P/E ratio is 8.00. In terms of profitability, LABFF's ROE is +0.39%, compared to PTCHF's ROE of -0.22%. Regarding short-term risk, LABFF is less volatile compared to PTCHF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs CLVLY Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, CLVLY has a market cap of 359.89M. Regarding current trading prices, LABFF is priced at $90.61, while CLVLY trades at $7.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas CLVLY's P/E ratio is 14.65. In terms of profitability, LABFF's ROE is +0.39%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, LABFF is less volatile compared to CLVLY. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs CLVLF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, CLVLF has a market cap of 348.36M. Regarding current trading prices, LABFF is priced at $90.61, while CLVLF trades at $6.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas CLVLF's P/E ratio is 14.18. In terms of profitability, LABFF's ROE is +0.39%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, LABFF and CLVLF have similar daily volatility (0.00).
LABFF vs IDRSF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, IDRSF has a market cap of 337.12M. Regarding current trading prices, LABFF is priced at $90.61, while IDRSF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas IDRSF's P/E ratio is -0.94. In terms of profitability, LABFF's ROE is +0.39%, compared to IDRSF's ROE of +0.24%. Regarding short-term risk, LABFF and IDRSF have similar daily volatility (0.00).
LABFF vs PRRUF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, PRRUF has a market cap of 321.29M. Regarding current trading prices, LABFF is priced at $90.61, while PRRUF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas PRRUF's P/E ratio is -11.00. In terms of profitability, LABFF's ROE is +0.39%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, LABFF is less volatile compared to PRRUF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs BOVNF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, BOVNF has a market cap of 309.28M. Regarding current trading prices, LABFF is priced at $90.61, while BOVNF trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas BOVNF's P/E ratio is -8.55. In terms of profitability, LABFF's ROE is +0.39%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, LABFF and BOVNF have similar daily volatility (0.00).
LABFF vs NGENF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, NGENF has a market cap of 302.73M. Regarding current trading prices, LABFF is priced at $90.61, while NGENF trades at $4.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas NGENF's P/E ratio is -15.59. In terms of profitability, LABFF's ROE is +0.39%, compared to NGENF's ROE of -2.23%. Regarding short-term risk, LABFF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs PBBIF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, PBBIF has a market cap of 286.93M. Regarding current trading prices, LABFF is priced at $90.61, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, LABFF's ROE is +0.39%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, LABFF is less volatile compared to PBBIF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs ORYZF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, ORYZF has a market cap of 234.86M. Regarding current trading prices, LABFF is priced at $90.61, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas ORYZF's P/E ratio is -43.29. In terms of profitability, LABFF's ROE is +0.39%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, LABFF and ORYZF have similar daily volatility (0.00).
LABFF vs NWPHF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, NWPHF has a market cap of 231.22M. Regarding current trading prices, LABFF is priced at $90.61, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas NWPHF's P/E ratio is N/A. In terms of profitability, LABFF's ROE is +0.39%, compared to NWPHF's ROE of N/A. Regarding short-term risk, LABFF and NWPHF have similar daily volatility (0.00).
LABFF vs MDCLF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, MDCLF has a market cap of 230.69M. Regarding current trading prices, LABFF is priced at $90.61, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, LABFF's ROE is +0.39%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, LABFF is less volatile compared to MDCLF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs HLOSF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, HLOSF has a market cap of 228.29M. Regarding current trading prices, LABFF is priced at $90.61, while HLOSF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas HLOSF's P/E ratio is -7.26. In terms of profitability, LABFF's ROE is +0.39%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, LABFF is less volatile compared to HLOSF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs SPHDF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, SPHDF has a market cap of 225.73M. Regarding current trading prices, LABFF is priced at $90.61, while SPHDF trades at $17.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas SPHDF's P/E ratio is -3.99. In terms of profitability, LABFF's ROE is +0.39%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, LABFF is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs RAONF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, RAONF has a market cap of 211.95M. Regarding current trading prices, LABFF is priced at $90.61, while RAONF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas RAONF's P/E ratio is -20.33. In terms of profitability, LABFF's ROE is +0.39%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, LABFF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs FPHAF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, FPHAF has a market cap of 209.54M. Regarding current trading prices, LABFF is priced at $90.61, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, LABFF's ROE is +0.39%, compared to FPHAF's ROE of N/A. Regarding short-term risk, LABFF and FPHAF have similar daily volatility (0.00).
LABFF vs VSBC Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, VSBC has a market cap of 207.03M. Regarding current trading prices, LABFF is priced at $90.61, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas VSBC's P/E ratio is N/A. In terms of profitability, LABFF's ROE is +0.39%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, LABFF and VSBC have similar daily volatility (0.00).
LABFF vs FGHQF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, FGHQF has a market cap of 205.61M. Regarding current trading prices, LABFF is priced at $90.61, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, LABFF's ROE is +0.39%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, LABFF is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs HNSBF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, HNSBF has a market cap of 203.44M. Regarding current trading prices, LABFF is priced at $90.61, while HNSBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas HNSBF's P/E ratio is -2.34. In terms of profitability, LABFF's ROE is +0.39%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, LABFF is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs BSEM Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, BSEM has a market cap of 196.40M. Regarding current trading prices, LABFF is priced at $90.61, while BSEM trades at $12.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas BSEM's P/E ratio is -21.09. In terms of profitability, LABFF's ROE is +0.39%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, LABFF is less volatile compared to BSEM. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs GNFTF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, GNFTF has a market cap of 176.25M. Regarding current trading prices, LABFF is priced at $90.61, while GNFTF trades at $3.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas GNFTF's P/E ratio is 8.85. In terms of profitability, LABFF's ROE is +0.39%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, LABFF is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs SCNLF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, SCNLF has a market cap of 176.05M. Regarding current trading prices, LABFF is priced at $90.61, while SCNLF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas SCNLF's P/E ratio is -5.66. In terms of profitability, LABFF's ROE is +0.39%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, LABFF and SCNLF have similar daily volatility (0.00).
LABFF vs OPORF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, OPORF has a market cap of 164.88M. Regarding current trading prices, LABFF is priced at $90.61, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas OPORF's P/E ratio is 12.00. In terms of profitability, LABFF's ROE is +0.39%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, LABFF is less volatile compared to OPORF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs MLLCF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, MLLCF has a market cap of 155.61M. Regarding current trading prices, LABFF is priced at $90.61, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas MLLCF's P/E ratio is -2.09. In terms of profitability, LABFF's ROE is +0.39%, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, LABFF is less volatile compared to MLLCF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs AVCTF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, AVCTF has a market cap of 153.80M. Regarding current trading prices, LABFF is priced at $90.61, while AVCTF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas AVCTF's P/E ratio is -3.34. In terms of profitability, LABFF's ROE is +0.39%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, LABFF is less volatile compared to AVCTF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs RECEF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, RECEF has a market cap of 149.84M. Regarding current trading prices, LABFF is priced at $90.61, while RECEF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas RECEF's P/E ratio is -10.00. In terms of profitability, LABFF's ROE is +0.39%, compared to RECEF's ROE of +2.26%. Regarding short-term risk, LABFF is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs BRIBF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, BRIBF has a market cap of 134.10M. Regarding current trading prices, LABFF is priced at $90.61, while BRIBF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas BRIBF's P/E ratio is -1.83. In terms of profitability, LABFF's ROE is +0.39%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, LABFF and BRIBF have similar daily volatility (0.00).
LABFF vs IPHYF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, IPHYF has a market cap of 133.63M. Regarding current trading prices, LABFF is priced at $90.61, while IPHYF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas IPHYF's P/E ratio is -2.13. In terms of profitability, LABFF's ROE is +0.39%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, LABFF is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs AAPGV Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, AAPGV has a market cap of 127.31M. Regarding current trading prices, LABFF is priced at $90.61, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas AAPGV's P/E ratio is N/A. In terms of profitability, LABFF's ROE is +0.39%, compared to AAPGV's ROE of N/A. Regarding short-term risk, LABFF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs PRNAF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, PRNAF has a market cap of 126.87M. Regarding current trading prices, LABFF is priced at $90.61, while PRNAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas PRNAF's P/E ratio is -1.39. In terms of profitability, LABFF's ROE is +0.39%, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, LABFF and PRNAF have similar daily volatility (0.00).
LABFF vs AMGXF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, AMGXF has a market cap of 121.79M. Regarding current trading prices, LABFF is priced at $90.61, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, LABFF's ROE is +0.39%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, LABFF is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs PSTTF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, PSTTF has a market cap of 117.53M. Regarding current trading prices, LABFF is priced at $90.61, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, LABFF's ROE is +0.39%, compared to PSTTF's ROE of N/A. Regarding short-term risk, LABFF and PSTTF have similar daily volatility (0.00).
LABFF vs EPRXF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, EPRXF has a market cap of 108.29M. Regarding current trading prices, LABFF is priced at $90.61, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, LABFF's ROE is +0.39%, compared to EPRXF's ROE of -1.99%. Regarding short-term risk, LABFF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs IUGNF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, IUGNF has a market cap of 104.54M. Regarding current trading prices, LABFF is priced at $90.61, while IUGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas IUGNF's P/E ratio is -1.40. In terms of profitability, LABFF's ROE is +0.39%, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, LABFF is less volatile compared to IUGNF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs ADOIF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, ADOIF has a market cap of 103.66M. Regarding current trading prices, LABFF is priced at $90.61, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, LABFF's ROE is +0.39%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, LABFF and ADOIF have similar daily volatility (0.00).
LABFF vs PBIGF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, PBIGF has a market cap of 100.04M. Regarding current trading prices, LABFF is priced at $90.61, while PBIGF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas PBIGF's P/E ratio is -8.56. In terms of profitability, LABFF's ROE is +0.39%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, LABFF is less volatile compared to PBIGF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs ADOCY Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, ADOCY has a market cap of 98.20M. Regarding current trading prices, LABFF is priced at $90.61, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, LABFF's ROE is +0.39%, compared to ADOCY's ROE of +1.73%. Regarding short-term risk, LABFF and ADOCY have similar daily volatility (0.00).
LABFF vs TRGNF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, TRGNF has a market cap of 92.35M. Regarding current trading prices, LABFF is priced at $90.61, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas TRGNF's P/E ratio is -2.19. In terms of profitability, LABFF's ROE is +0.39%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, LABFF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs CMVLF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, CMVLF has a market cap of 90.12M. Regarding current trading prices, LABFF is priced at $90.61, while CMVLF trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas CMVLF's P/E ratio is -3.05. In terms of profitability, LABFF's ROE is +0.39%, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, LABFF is less volatile compared to CMVLF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs MCURF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, MCURF has a market cap of 86.53M. Regarding current trading prices, LABFF is priced at $90.61, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas MCURF's P/E ratio is -16.90. In terms of profitability, LABFF's ROE is +0.39%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, LABFF is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs MSCLF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, MSCLF has a market cap of 82.59M. Regarding current trading prices, LABFF is priced at $90.61, while MSCLF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas MSCLF's P/E ratio is 2.77. In terms of profitability, LABFF's ROE is +0.39%, compared to MSCLF's ROE of -0.74%. Regarding short-term risk, LABFF is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs ACHFF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, ACHFF has a market cap of 79.09M. Regarding current trading prices, LABFF is priced at $90.61, while ACHFF trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas ACHFF's P/E ratio is -30.00. In terms of profitability, LABFF's ROE is +0.39%, compared to ACHFF's ROE of +0.56%. Regarding short-term risk, LABFF is less volatile compared to ACHFF. This indicates potentially lower risk in terms of short-term price fluctuations for LABFF.
LABFF vs KNTPF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, KNTPF has a market cap of 77.03M. Regarding current trading prices, LABFF is priced at $90.61, while KNTPF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas KNTPF's P/E ratio is -3.55. In terms of profitability, LABFF's ROE is +0.39%, compared to KNTPF's ROE of -4.62%. Regarding short-term risk, LABFF and KNTPF have similar daily volatility (0.00).
LABFF vs ETXPF Comparison
LABFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABFF stands at 4.63B. In comparison, ETXPF has a market cap of 75.96M. Regarding current trading prices, LABFF is priced at $90.61, while ETXPF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABFF currently has a P/E ratio of 28.95, whereas ETXPF's P/E ratio is -6.50. In terms of profitability, LABFF's ROE is +0.39%, compared to ETXPF's ROE of -0.36%. Regarding short-term risk, LABFF and ETXPF have similar daily volatility (0.00).